PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation

Activation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The incr...

Full description

Bibliographic Details
Main Authors: Karine Hellemans, Krista Rombouts, Erik Quartier, Andrea S. Dittié, Andreas Knorr, Liliane Michalik, Vera Rogiers, Frans Schuit, Walter Wahli, Andrea Geerts
Format: Article
Language:English
Published: Elsevier 2003-02-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520312153
id doaj-4199ff612a9a4144983a88fe13821af9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Karine Hellemans
Krista Rombouts
Erik Quartier
Andrea S. Dittié
Andreas Knorr
Liliane Michalik
Vera Rogiers
Frans Schuit
Walter Wahli
Andrea Geerts
spellingShingle Karine Hellemans
Krista Rombouts
Erik Quartier
Andrea S. Dittié
Andreas Knorr
Liliane Michalik
Vera Rogiers
Frans Schuit
Walter Wahli
Andrea Geerts
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
Journal of Lipid Research
liver fibrosis
peroxisome proliferator-activated receptor β
fatty acid binding protein
CD36
ACS2
cellular retinol binding protein
author_facet Karine Hellemans
Krista Rombouts
Erik Quartier
Andrea S. Dittié
Andreas Knorr
Liliane Michalik
Vera Rogiers
Frans Schuit
Walter Wahli
Andrea Geerts
author_sort Karine Hellemans
title PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
title_short PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
title_full PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
title_fullStr PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
title_full_unstemmed PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
title_sort pparβ regulates vitamin a metabolism-related gene expression in hepatic stellate cells undergoing activation
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2003-02-01
description Activation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The increased expression of CRBP-I and LRAT during hepatic stellate cells activation, both involved in retinol esterification, was in contrast with the simultaneous depletion of their typical lipid-vitamin A (vitA) reserves. Since hepatic stellate cells express high levels of peroxisome proliferator activated receptor β (PPARβ), which become further induced during transition into the activated phenotype, we investigated the potential role of PPARβ in the regulation of these changes. Administration of L165041, a PPARβ-specific agonist, further induced the expression of CD36, B-FABP, CRBP-I, and LRAT, whereas their expression was inhibited by antisense PPARβ mRNA. PPARβ-RXR dimers bound to CRBP-I promoter sequences.Our observations suggest that PPARβ regulates the expression of these genes, and thus could play an important role in vitA storage. In vivo, we observed a striking association between the enhanced expression of PPARβ and CRBP-I in activated myofibroblast-like hepatic stellate cells and the manifestation of vitA autofluorescent droplets in the fibrotic septa after injury with CCl4 or CCl4 in combination with retinol.
topic liver fibrosis
peroxisome proliferator-activated receptor β
fatty acid binding protein
CD36
ACS2
cellular retinol binding protein
url http://www.sciencedirect.com/science/article/pii/S0022227520312153
work_keys_str_mv AT karinehellemans pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT kristarombouts pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT erikquartier pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT andreasdittie pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT andreasknorr pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT lilianemichalik pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT verarogiers pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT fransschuit pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT walterwahli pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
AT andreageerts pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation
_version_ 1721507006632689664
spelling doaj-4199ff612a9a4144983a88fe13821af92021-04-27T04:39:21ZengElsevierJournal of Lipid Research0022-22752003-02-01442280295PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activationKarine Hellemans0Krista Rombouts1Erik Quartier2Andrea S. Dittié3Andreas Knorr4Liliane Michalik5Vera Rogiers6Frans Schuit7Walter Wahli8Andrea Geerts9Laboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandActivation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The increased expression of CRBP-I and LRAT during hepatic stellate cells activation, both involved in retinol esterification, was in contrast with the simultaneous depletion of their typical lipid-vitamin A (vitA) reserves. Since hepatic stellate cells express high levels of peroxisome proliferator activated receptor β (PPARβ), which become further induced during transition into the activated phenotype, we investigated the potential role of PPARβ in the regulation of these changes. Administration of L165041, a PPARβ-specific agonist, further induced the expression of CD36, B-FABP, CRBP-I, and LRAT, whereas their expression was inhibited by antisense PPARβ mRNA. PPARβ-RXR dimers bound to CRBP-I promoter sequences.Our observations suggest that PPARβ regulates the expression of these genes, and thus could play an important role in vitA storage. In vivo, we observed a striking association between the enhanced expression of PPARβ and CRBP-I in activated myofibroblast-like hepatic stellate cells and the manifestation of vitA autofluorescent droplets in the fibrotic septa after injury with CCl4 or CCl4 in combination with retinol.http://www.sciencedirect.com/science/article/pii/S0022227520312153liver fibrosisperoxisome proliferator-activated receptor βfatty acid binding proteinCD36ACS2cellular retinol binding protein